Synthetic cannabinoids that bind to cannabinoid receptors CB1 and CB2 have been shown to inhibit migration, metastasis, and invasion of various cell types including breast cancer cells [4], [5], [6], [37], [41]. The gene discussed is CNR2; the disease is breast carcinoma.